Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$307M |
| 2 |
Vanguard Morningstar Value ETF
VTV
|
+$294M |
| 3 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$246M |
| 4 |
Costco
COST
|
+$225M |
| 5 |
Lyft
LYFT
|
+$223M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ferguson
FERG
|
+$692M |
| 2 |
Linde
LIN
|
+$624M |
| 3 |
Medtronic
MDT
|
+$527M |
| 4 |
Goldman Sachs
GS
|
+$340M |
| 5 |
Microsoft
MSFT
|
+$301M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.25% |
| 2 | Healthcare | 13.3% |
| 3 | Financials | 12.53% |
| 4 | Consumer Discretionary | 10.81% |
| 5 | Communication Services | 8.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2001
Tootsie Roll Industries
TR
$3.08B
| $12.6M | ﹤0.01% |
431,901
+7,123
| +2% | +$201K |
|
2002
ChargePoint
CHPT
$160M
| $12.6M | ﹤0.01% |
+18,166
| New | +$9.62M |
|
2003
Ethan Allen Interiors
ETD
$581M
| $12.6M | ﹤0.01% |
457,282
-10,665
| -2% | -$308K |
|
2004
Core Laboratories
CLB
$571M
| $12.6M | ﹤0.01% |
323,899
-60,072
| -16% | -$2.15M |
|
2005
United Parks & Resorts
PRKS
$2.04B
| $12.6M | ﹤0.01% |
252,329
-4,321
| -2% | -$229K |
|
2006
iHeartMedia
IHRT
$457M
| $12.6M | ﹤0.01% |
467,879
+179,846
| +62% | +$3.98M |
|
|
FARO
2007
DELISTED
Faro Technologies
FARO
| $12.6M | ﹤0.01% |
161,713
-23,394
| -13% | -$1.84M |
|
2008
Bausch Health
BHC
$2.43B
| $12.6M | ﹤0.01% |
428,331
-19,247
| -4% | -$583K |
|
|
HSII
2009
DELISTED
Heidrick & Struggles
HSII
| $12.5M | ﹤0.01% |
280,907
-11,961
| -4% | -$500K |
|
|
PRMW
2010
DELISTED
Primo Water Corporation
PRMW
| $12.5M | ﹤0.01% |
747,309
+166,452
| +29% | +$2.81M |
|
2011
Lazard
LAZ
$4.35B
| $12.5M | ﹤0.01% |
276,297
-11,137
| -4% | -$511K |
|
2012
Regenxbio
RGNX
$711M
| $12.4M | ﹤0.01% |
320,004
-29,129
| -8% | -$1.04M |
|
|
SAVE
2013
DELISTED
Spirit Airlines, Inc.
SAVE
| $12.4M | ﹤0.01% |
408,268
+16,941
| +4% | +$595K |
|
2014
West Fraser Timber
WFG
$5.54B
| $12.4M | ﹤0.01% |
173,271
-254,317
| -59% | -$19.5M |
|
2015
Goosehead Insurance
GSHD
$2.35B
| $12.4M | ﹤0.01% |
97,505
+18,251
| +23% | +$1.86M |
|
|
AVYA
2016
DELISTED
Avaya Holdings Corp. Common Stock
AVYA
| $12.4M | ﹤0.01% |
459,404
-27,827
| -6% | -$783K |
|
2017
AngioDynamics
ANGO
$655M
| $12.4M | ﹤0.01% |
455,332
+9,268
| +2% | +$226K |
|
|
USCR
2018
DELISTED
U S Concrete, Inc.
USCR
| $12.3M | ﹤0.01% |
166,983
-36,882
| -18% | -$2.39M |
|
2019
Cytokinetics
CYTK
$10.3B
| $12.3M | ﹤0.01% |
622,586
-64,576
| -9% | -$1.52M |
|
2020
iShares Core S&P Total US Stock Market ETF
ITOT
$98.3B
| $12.3M | ﹤0.01% |
124,477
+12,990
| +12% | +$1.25M |
|
2021
Astrana Health
ASTH
$2.02B
| $12.3M | ﹤0.01% |
195,558
+86,651
| +80% | +$3.2M |
|
2022
Acadia Pharmaceuticals
ACAD
$4.87B
| $12.2M | ﹤0.01% |
500,804
+70,281
| +16% | +$1.59M |
|
|
DCH
2023
Dauch Corp
DCH
$1.6B
| $12.2M | ﹤0.01% |
1,179,777
-94,925
| -7% | -$998K |
|
2024
Casella Waste Systems
CWST
$5.77B
| $12.2M | ﹤0.01% |
191,897
+4,102
| +2% | +$272K |
|
2025
Agilysys
AGYS
$3.22B
| $12.1M | ﹤0.01% |
212,783
-19,227
| -8% | -$994K |
|
Similar funds
Bank of New York Mellon's Q2 2021 Portfolio in Review
As of Q2 2021, Bank of New York Mellon held 4,590 positions worth $517B, up 5.6% from $489B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Bank of New York Mellon's Q2 2021 filing shows 277 new, 1,772 increased, 2,129 reduced and 201 closed positions. Its largest new stake was Organon & Co: 4,240,135 shares worth $128M. The largest sale was Ferguson, an estimated $692M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.
- Bank of New York Mellon's largest Q2 2021 buy was Organon & Co: 4,240,135 shares worth $128M.
- Bank of New York Mellon added most to Vanguard FTSE Developed Markets ETF in Q2 2021, an estimated $307M increase.
- Bank of New York Mellon's biggest Q2 2021 reduction was Ferguson, cutting an estimated $692M.
- Bank of New York Mellon fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $164M.
- Bank of New York Mellon's ten largest holdings make up 19% of its $517B portfolio in Q2 2021.
- Bank of New York Mellon opened 277 new positions and closed 201 in Q2 2021.
- Bank of New York Mellon's portfolio value rose 5.6% quarter-over-quarter to $517B.
Based on Bank of New York Mellon's 13F filing for Q2 2021, filed 11 Aug 2021.